{
  "docId": "019dd923-5e88-73ef-bd5a-0ab1717fb738",
  "docSlug": "7ec40cabf8e4d071",
  "documentTitle": "Fresenius SE 2023 06 13 14 Goldman Sachs 44th Annual Global Healthcare Conference",
  "authorId": "GoldmanSachs",
  "authorName": "Fresenius",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "equity_research",
  "sourceTypeLabel": "Equity research",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 47,
  "pageCount": 58,
  "prevPage": 46,
  "nextPage": 48,
  "slideType": "kpi_dashboard",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 20,
  "notes": "The table displays financial metrics including EBITDA, EBIT, and margins for Total, Growth Vectors, Pharma, and Corporate segments.",
  "elementsJson": [
    "data_table",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5e88-73ef-bd5a-0ab1717fb738/47",
  "deckHref": "/decks/019dd923-5e88-73ef-bd5a-0ab1717fb738",
  "deckJsonHref": "/decks/019dd923-5e88-73ef-bd5a-0ab1717fb738.json",
  "deckAnchorHref": "/decks/019dd923-5e88-73ef-bd5a-0ab1717fb738#slide-47",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.65,
        "x": 0.03,
        "y": 0.85
      },
      "kind": "disclaimer",
      "text": "All figures before special items. Margin growth at actual rates. 1 consists of MedTech, Nutrition, Biopharma. For a detailed overview of special items and adjustments please see the reconciliation tables provided on our website.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d3195db2-0d4d-45ee-9352-9ba6b64f5998",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "EBITDA: 403",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-1d6d-7403-aea1-735a73219a1b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.6,
        "x": 0.15,
        "y": 0.28
      },
      "kind": "table",
      "text": "Total EBITDA, Growth Vectors, Pharma (IV Drugs & Fluids), Corporate, Total EBIT with Q1/23 and YoY cc metrics",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "459e9796-5f72-4455-a90f-d1acbae701d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.45,
        "x": 0.03,
        "y": 0.09
      },
      "kind": "title",
      "text": "Fresenius Kabi: Q1/23 EBIT(DA) development",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aab0c161-8236-4cbf-b4db-cae21e0723d9",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "983d44bd-d399-4682-b2e9-014c2376ed19",
      "evidence": "The slide title 'Fresenius Kabi: Q1/23 EBIT(DA) development' and the table/data component suggest a waterfall chart, which is used to display the development of EBIT(DA).",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}